The US is the bigger Artificial Intelligence (AI) in Drugs Discovery market: $252 Mn against $11 Mn in 2023, about 23 times as large.
India grows faster: 29.1% a year, against 24.1%. The gap still grows from $241 Mn to $2 Bn by 2033.
Clinical research: 114 active trials in the US, 3 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $252 Mn | $11 Mn |
| Market size, 2033 projected | $2.2 Bn | $140 Mn |
| Growth a year (CAGR) | 24.1% | 29.1% |
| Money added, 2023–2033 | $1.9 Bn | $129 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $0.74 | $0.01 |
| Active clinical trials | 114 | 3 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Artificial Intelligence (AI) in Drugs Discovery, US or India?
The US is the bigger Artificial Intelligence (AI) in Drugs Discovery market: $252 Mn against $11 Mn in 2023, about 23 times as large.
Which grows faster in Artificial Intelligence (AI) in Drugs Discovery, US or India?
India grows faster: 29.1% a year, against 24.1%. The gap still grows from $241 Mn to $2 Bn by 2033.
More Artificial Intelligence (AI) in Drugs Discovery comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.